- Home
- OKYO vs CDLX Comparison
OKYO vs CDLX Comparison
Compare OKYO & CDLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OKYO
- CDLX
- Stock Information
- Founded
- OKYO 2007
- CDLX 2008
- Country
- OKYO United Kingdom
- CDLX United States
- Employees
- OKYO N/A
- CDLX N/A
- Industry
- OKYO Biotechnology: Biological Products (No Diagnostic Substances)
- CDLX Computer Software: Programming Data Processing
- Sector
- OKYO Health Care
- CDLX Technology
- Exchange
- OKYO Nasdaq
- CDLX Nasdaq
- Market Cap
- OKYO 95.3M
- CDLX 93.5M
- IPO Year
- OKYO 2022
- CDLX 2018
- Fundamental
- Price
- OKYO $2.37
- CDLX $1.11
- Analyst Decision
- OKYO Strong Buy
- CDLX Hold
- Analyst Count
- OKYO 1
- CDLX 5
- Target Price
- OKYO $7.00
- CDLX $3.25
- AVG Volume (30 Days)
- OKYO 188.6K
- CDLX 1.4M
- Earning Date
- OKYO 07-18-2025
- CDLX 08-06-2025
- Dividend Yield
- OKYO N/A
- CDLX N/A
- EPS Growth
- OKYO N/A
- CDLX N/A
- EPS
- OKYO N/A
- CDLX N/A
- Revenue
- OKYO N/A
- CDLX $266,201,000.00
- Revenue This Year
- OKYO N/A
- CDLX N/A
- Revenue Next Year
- OKYO N/A
- CDLX $5.51
- P/E Ratio
- OKYO N/A
- CDLX N/A
- Revenue Growth
- OKYO N/A
- CDLX N/A
- 52 Week Low
- OKYO $0.85
- CDLX $0.95
- 52 Week High
- OKYO $3.35
- CDLX $5.25
- Technical
- Relative Strength Index (RSI)
- OKYO 40.19
- CDLX 36.47
- Support Level
- OKYO $2.20
- CDLX $0.95
- Resistance Level
- OKYO $2.51
- CDLX $1.32
- Average True Range (ATR)
- OKYO 0.25
- CDLX 0.14
- MACD
- OKYO -0.09
- CDLX -0.04
- Stochastic Oscillator
- OKYO 14.80
- CDLX 15.69
About OKYO OKYO Pharma Limited
OKYO Pharma Ltd is a biopharmaceutical company. The company is developing therapeutics to improve the lives of patients with inflammatory eye diseases and chronic pain. It offers solutions for various diseases such as Dry Eye Disease, Non-infectious Anterior Uveitis, Allergenic Conjunctivitis, Chronic Pain, and Ocular Pain.
About CDLX Cardlytics Inc.
Cardlytics Inc operates an advertising platform within financial institutions' digital channels, which include online, mobile, email, and various real-time notifications. The company operates through segments namely, Cardlytics platform in the U.S. and U.K. and the Bridg platform. The Cardlytics platform segment which generates key revenue, operates a proprietary native bank advertising channel that enables marketers to reach consumers through their trusted and frequently visited online and mobile banking channels. The Bridg platform generates revenue through the sale of subscriptions to the cloud-based customer-data platform and the delivery of professional services like implementation, onboarding, and technical support. The company receives maximum revenue from the United States.